Storyline

Novel molecular targets show promise in Alzheimer's disease models

Recent preclinical studies highlight new therapeutic targets addressing neurovascular and mitochondrial dysfunction in Alzheimer's disease (AD).

Evidence locked

Today's free sample is only available for the edition's flagship storyline.

Evidence preview